Ascendis Pharma
ASND
ASND
245 hedge funds and large institutions have $10.9B invested in Ascendis Pharma in 2025 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 82 increasing their positions, 87 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 242 → 245 (+3)
6% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 87
4.51% less ownership
Funds ownership: 107.4% → 102.88% (-4.5%)
Holders
245
Holding in Top 10
16
Calls
$39.2M
Puts
$12.6M
Top Buyers
| 1 | +$166M | |
| 2 | +$91.4M | |
| 3 | +$57M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$54M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$29.7M |
Top Sellers
| 1 | -$285M | |
| 2 | -$92.8M | |
| 3 | -$88.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$65.7M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$45.9M |
